Therapeutic inflammatory monocyte modulation using immune-modifying microparticles

Science Translational Medicine

Volumn 6, Issue 219, 2014, Pages

  Getts, Daniel R ^a,b,c   Terry, Rachael L ^a,b   Getts, Meghann Teague ^b   Deffrasnes, Celine ^a   Müller, Marcus ^d   Vreden, Carynvan ^a   Ashhurst, Thomas M ^a   Chami, Belal ^a   McCarthy, Derrick ^b   Wu, Huiling ^e   Jin, Ma ^e   Martin, Aaron ^b   Shae, Lonnie D ^f   Witting, Paul ^a   Kansas, Geoffrey S ^b   Kühn, Joachim ^g   Hafezi, Wali ^g   Campbell, Iain L ^h   Reilly, David ^h   Say, Jana ⁱ   Brown, Louise ⁱ   White, Melanie Y ^h   Cordwell, Stuart J ^h   Chadban, Steven J ^e   Thorp, Edward B ^b   Bao, Shisan ^a   Miller, Stephen D ^b   King, Nicholas J C ^a   more..

^a UNIVERSITY OF SYDNEY   (Australia)

^b NORTHWESTERN UNIVERSITY   (United States)

^c Cour Pharmaceutical Development Company ^*  (United States)

^d UNIVERSITY HOSPITAL BONN   (Germany)

^e ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^f Northwestern University   (United States)

^g UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^h UNIVERSITY OF SYDNEY   (Australia)

ⁱ MACQUARIE UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; DIAMOND; IMMUNE MODIFYING MICROPARTICLE; IMMUNOMODULATING AGENT; MACROPHAGE RECEPTOR; OPSONIN; POLYGLACTIN; POLYSTYRENE; SCAVENGER RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BRAIN; CLEARANCE; COLITIS; CONTROLLED STUDY; DISEASE MODEL; DRUG DISTRIBUTION; DRUG EFFICACY; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; FEMALE; HEART INFARCTION; IMMUNOMODULATION; INFLAMMATORY BOWEL DISEASE; INFLAMMATORY MONOCYTE; LEUKOCYTE FUNCTION; LEUKOCYTE MIGRATION; MONOCYTE; MOUSE; NONHUMAN; PERITONITIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN STRUCTURE; REPERFUSION INJURY; SPLEEN; SURVIVAL; TISSUE REPAIR; VIRUS ENCEPHALITIS; WEST NILE FLAVIVIRUS;

ANIMALS; APOPTOSIS; BRAIN; CELL MOVEMENT; CELL SURVIVAL; COLITIS; DISEASE MODELS, ANIMAL; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; INFLAMMATION; INFLAMMATORY BOWEL DISEASES; KIDNEY; MACROPHAGES; MICE; MICE, INBRED C57BL; MICROSPHERES; MONOCYTES; MYOCARDIUM; PARTICLE SIZE; PERITONEUM; POLYSTYRENES; RECEPTORS, IMMUNOLOGIC; REPERFUSION INJURY; SPLEEN; WEST NILE FEVER;

EID: 84893364090     PISSN: 19466234     EISSN: 19466242     Source Type: Journal    
DOI: 10.1126/scitranslmed.3007563     Document Type: Article

References (58)

1. C. C. Bain, C. L. Scott, H. Uronen-Hansson, S. Gudjonsson, O. Jansson, O. Grip, M. Guilliams, B. Malissen, W. W. Agace, A. M. Mowat, Resident and pro-inflammatory macrophages in the colon represent alternative context-dependent fates of the same Ly6Chi monocyte precursors. Mucosal Immunol. 6, 498-510 (2013).
2. D. R. Getts, R. L. Terry, M. T. Getts, M. Müller, S. Rana, B. Shrestha, J. Radford, N. Van Rooijen, I. L. Campbell, N. J. King, Ly6c+ "inflammatory monocytes " are microglial precursors recruited in a pathogenic manner in West Nile virus encephalitis. J. Exp. Med. 205, 2319-2337 (2008).
3. I. L. King, T. L. Dickendesher, B. M. Segal, Circulating Ly-6C+ myeloid precursors migrate to the CNS and play a pathogenic role during autoimmune demyelinating disease. Blood 113, 3190-3197 (2009).
4. K. L. Lin, S. Sweeney, B. D. Kang, E. Ramsburg, M. D. Gunn, CCR2-antagonist prophylaxis reduces pulmonary immune pathology and markedly improves survival during influenza infection. J. Immunol. 186, 508-515 (2011).
5. A. Schiopu, S. N. Nadig, O. S. Cotoi, J. Hester, N. van Rooijen, K. J. Wood, Inflammatory Ly- 6Chi monocytes play an important role in the development of severe transplant arteriosclerosis in hyperlipidemic recipients. Atherosclerosis 223, 291-298 (2012).
6. F. K. Swirski, M. Wildgruber, T. Ueno, J. L. Figueiredo, P. Panizzi, Y. Iwamoto, E. Zhang, J. R. Stone, E. Rodriguez, J. W. Chen, M. J. Pittet, R. Weissleder, M. Nahrendorf, Myeloperoxidase-rich Ly-6C+ myeloid cells infiltrate allografts and contribute to an imaging signature of organ rejection in mice. J. Clin. Invest. 120, 2627-2634 (2010).
7. A. Waddell, R. Ahrens, K. Steinbrecher, B. Donovan, M. E. Rothenberg, A. Munitz, S. P. Hogan, Colonic eosinophilic inflammation in experimental colitis is mediated by Ly6Chigh CCR2+ inflammatory monocyte/macrophage-derived CCL11. J. Immunol. 186, 5993-6003 (2011).
8. K. E. Berg, I. Ljungcrantz, L. Andersson, C. Bryngelsson, B. Hedblad, G. N. Fredrikson, J. Nilsson, H. Björkbacka, Elevated CD14++ CD16- monocytes predict cardiovascular events. Circ. Cardiovasc. Genet. 5, 122-131 (2012).
9. F. Tacke, D. Alvarez, T. J. Kaplan, C. Jakubzick, R. Spanbroek, J. Llodra, A. Garin, J. Liu, M. Mack, N. van Rooijen, S. A. Lira, A. J. Habenicht, G. J. Randolph, Monocyte subsets differentially employ CCR2, CCR5, and CX3CR1 to accumulate within atherosclerotic plaques. J. Clin. Invest. 117, 185-194 (2007).
10. F. K. Swirski, M. Nahrendorf, M. Etzrodt, M. Wildgruber, V. Cortez-Retamozo, P. Panizzi, J. L. Figueiredo, R. H. Kohler, A. Chudnovskiy, P. Waterman, E. Aikawa, T. R. Mempel, P. Libby, R. Weissleder, M. J. Pittet, Identification of splenic reservoir monocytes and their deployment to inflammatory sites. Science 325, 612-616 (2009).
11. D. R. Getts, R. L. Terry, M. T. Getts, M. Muller, S. Rana, C. Deffrasnes, T. M. Ashhurst, J. Radford, M. Hofer, S. Thomas, I. L. Campbell, N. J. King, Targeted blockade in lethal West Nile virus encephalitis indicates a crucial role for very late antigen (VLA)-4-dependent recruitment of nitric oxide-producing macrophages. J. Neuroinflamm. 9, 246 (2012).
12. C. M. Buckner, T. M. Calderon, D. W. Willams, T. J. Belbin, J. W. Berman, Characterization of monocytematuration/differentiation that facilitates their transmigration across the blood-brain barrier and infection by HIV: Implications for NeuroAIDS. Cell. Immunol. 267, 109-123 (2011).
13. M. A. Ingersoll, R. Spanbroek, C. Lottaz, E. L. Gautier, M. Frankenberger, R. Hoffmann, R. Lang, M. Haniffa, M. Collin, F. Tacke, A. J. Habenicht, L. Ziegler-Heitbrock, G. J. Randolph, Comparison of gene expression profiles between human and mouse monocyte subsets. Blood 115, e10-e19 (2010).
14. H. W. Zimmermann, S. Seidler, J. Nattermann, N. Gassler, C. Hellerbrand, A. Zernecke, J. J. Tischendorf, T. Luedde, R. Weiskirchen, C. Trautwein, F. Tacke, Functional contribution of elevated circulating and hepatic non-classical CD14CD16 monocytes to inflammation and human liver fibrosis. PLOS One 5, e11049 (2010).
15. K. J. Katschke Jr., J. B. Rottman, J. H. Ruth, S. Qin, L. Wu, G. LaRosa, P. Ponath, C. C. Park, R. M. Pope, A. E. Koch, Differential expression of chemokine receptors on peripheral blood, synovial fluid, and synovial tissue monocytes/macrophages in rheumatoid arthritis. Arthritis Rheum. 44, 1022-1032 (2001).
16. O. Butovsky, S. Siddiqui, G. Gabriely, A. J. Lanser, B. Dake, G. Murugaiyan, C. E. Doykan, P. M. Wu, R. R. Gali, L. K. Iyer, R. Lawson, J. Berry, A. M. Krichevsky, M. E. Cudkowicz, H. L. Weiner, Modulating inflammatory monocytes with a unique microRNA gene signature ameliorates murine ALS. J. Clin. Invest. 122, 3063-3087 (2012).
17. M. Nahrendorf, M. J. Pittet, F. K. Swirski, Monocytes: Protagonists of infarct inflammation and repair after myocardial infarction. Circulation 121, 2437-2445 (2010).
18. F. Leuschner, P. Dutta, R. Gorbatov, T. I. Novobrantseva, J. S. Donahoe, G. Courties, K. M. Lee, J. I. Kim, J. F. Markmann, B. Marinelli, P. Panizzi, W. W. Lee, Y. Iwamoto, S. Milstein, H. Epstein-Barash, W. Cantley, J. Wong, V. Cortez-Retamozo, A. Newton, K. Love, P. Libby, M. J. Pittet, F. K. Swirski, V. Koteliansky, R. Langer, R. Weissleder, D. G. Anderson, M. Nahrendorf, Therapeutic siRNA silencing in inflammatory monocytes in mice. Nat. Biotechnol. 29, 1005-1010 (2011).
19. J. Couzin-Frankel, Drug research. Roche exits RNAi field, cuts 4800 jobs. Science 330, 1163 (2010).
20. Y. S. Kang, J. J. Cha, Y. Y. Hyun, D. R. Cha, Novel C-C chemokine receptor 2 antagonists in metabolic disease: A review of recent developments. Expert Opin. Investig. Drugs 20, 745-756 (2011).
21. P. Boros, J. C. Ochando, S. H. Chen, J. S. Bromberg, Myeloid-derived suppressor cells: Natural regulators for transplant tolerance. Hum. Immunol. 71, 1061-1066 (2010).
22. E. Shantsila, B. Wrigley, L. Tapp, S. Apostolakis, S. Montoro-Garcia, M. T. Drayson, G. Y. Lip, Immunophenotypic characterization of human monocyte subsets: Possible implications for cardiovascular disease pathophysiology. J. Thromb. Haemost. 9, 1056-1066 (2011).
23. P. L. Rodriguez, T. Harada, D. A. Christian, D. A. Pantano, R. K. Tsai, D. E. Discher, Minimal "self" peptides that inhibit phagocytic clearance and enhance delivery of nanoparticles. Science 339, 971-975 (2013).
24. D. R. Getts, I. Matsumoto, M. Müller, M. T. Getts, J. Radford, B. Shrestha, I. L. Campbell, N. J. King, Role of IFN-g in an experimental murine model of West Nile virus-induced seizures. J. Neurochem. 103, 1019-1030 (2007).
25. T. Farrah, E. W. Deutsch, G. S. Omenn, D. S. Campbell, Z. Sun, J. A. Bletz, P. Mallick, J. E. Katz, J. Malmström, R. Ossola, J. D. Watts, B. Lin, H. Zhang, R. L. Moritz, R. Aebersold, A high-confidence human plasma proteome reference set with estimated concentrations in PeptideAtlas. Mol. Cell. Proteomics 10, M110.006353 (2011).
26. J. A. Kamps, G. L. Scherphof, Receptor versus non-receptor mediated clearance of liposomes. Adv. Drug Deliv. Rev. 32, 81-97 (1998).
27. A. J. Andersen, S. H. Hashemi, T. L. Andresen, A. C. Hunter, S. M. Moghimi, Complement: Alive and kicking nanomedicines. J. Biomed. Nanotechnol. 5, 364-372 (2009).
28. S. K. Chao, R. F. Hamilton, J. C. Pfau, A. Holian, Cell surface regulation of silica-induced apoptosis by the SR-A scavenger receptor in a murine lung macrophage cell line (MH-S). Toxicol. Appl. Pharmacol. 174, 10-16 (2001).
29. Y. Chao, M. Makale, P. P. Karmali, Y. Sharikov, I. Tsigelny, S. Merkulov, S. Kesari, W. Wrasidlo, E. Ruoslahti, D. Simberg, Recognition of dextran-superparamagnetic iron oxide nanoparticle conjugates (Feridex) via macrophage scavenger receptor charged domains. Bioconjug. Chem. 23, 1003-1009 (2012).
30. S. Reagan-Shaw, M. Nihal, N. Ahmad, Dose translation from animal to human studies revisited. FASEB J. 22, 659-661 (2008).
31. C. L. Tsou, W. Peters, Y. Si, S. Slaymaker, A. M. Aslanian, S. P. Weisberg, M. Mack, I. F. Charo, Critical roles for CCR2 and MCP-3 in monocyte mobilization from bone marrow and recruitment to inflammatory sites. J. Clin. Invest. 117, 902-909 (2007).
32. Y. Chao, P. P. Karmali, R. Mukthavaram, S. Kesari, V. L. Kouznetsova, I. F. Tsigelny, D. Simberg, Direct recognition of superparamagnetic nanocrystals by macrophage scavenger receptor SR-AI. ACS Nano 7, 4289-4298 (2013).
33. D. R. Getts, A. J. Martin, D. P. McCarthy, R. L. Terry, Z. N. Hunter, W. T. Yap, M. T. Getts, M. Pleiss, X. Luo, N. J. King, L. D. Shea, S. D. Miller, Microparticles bearing encephalitogenic peptides induce T-cell tolerance and ameliorate experimental autoimmune encephalomyelitis. Nat. Biotechnol. 30, 1217-1224 (2012).
34. D. R. Getts, D. M. Turley, C. E. Smith, C. T. Harp, D. McCarthy, E. M. Feeney, M. T. Getts, A. J. Martin, X. Luo, R. L. Terry, N. J. King, S. D. Miller, Tolerance induced by apoptotic antigen-coupled leukocytes is induced by PD-L1+ and IL-10-producing splenic macrophages and maintained by T regulatory cells. J. Immunol. 187, 2405-2417 (2011).
35. S. Kanno, A. Furuyama, S. Hirano, A murine scavenger receptor MARCO recognizes polystyrene nanoparticles. Toxicol. Sci. 97, 398-406 (2007).
36. P. Aichele, J. Zinke, L. Grode, R. A. Schwendener, S. H. Kaufmann, P. Seiler, Macrophages of the splenic marginal zone are essential for trapping of blood-borne particulate antigen but dispensable for induction of specific T cell responses. J. Immunol. 171, 1148-1155 (2003).
37. M. G. Dorrington, A. M. Roche, S. E. Chauvin, Z. Tu, K. L. Mossman, J. N. Weiser, D. M. Bowdish, MARCO is required for TLR2- and Nod2-mediated responses to Streptococcus pneumoniae and clearance of pneumococcal colonization in the murine nasopharynx. J. Immunol. 190, 250-258 (2013).
38. K. J. Min, H. J. Um, K. H. Cho, T. K. Kwon, Curcumin inhibits oxLDL-induced CD36 expression and foam cell formation through the inhibition of p38 MAPK phosphorylation. Food Chem. Toxicol. 58, 77-85 (2013).
39. R. S. Schwartz, Y. Tanaka, I. J. Fidler, D. T. Chiu, B. Lubin, A. J. Schroit, Increased adherence of sickled and phosphatidylserine-enriched human erythrocytes to cultured human peripheral blood monocytes. J. Clin. Invest. 75, 1965-1972 (1985).
40. A. J. Schroit, J. W. Madsen, Y. Tanaka, In vivo recognition and clearance of red blood cells containing phosphatidylserine in their plasmamembranes. J. Biol. Chem. 260, 5131-5138 (1985).
41. S. J. Lee, S. Y. Park, M. Y. Jung, S. M. Bae, I. S. Kim, Mechanism for phosphatidylserine-dependent erythrophagocytosis in mouse liver. Blood 117, 5215-5223 (2011).
42. S. L. Bailey, B. Schreiner, E. J. McMahon, S. D. Miller, CNS myeloid DCs presenting endogenous myelin peptides 'preferentially' polarize CD4+ TH-17 cells in relapsing EAE. Nat. Immunol. 8, 172-180 (2007).
43. F. Leuschner, P. J. Rauch, T. Ueno, R. Gorbatov, B. Marinelli, W. W. Lee, P. Dutta, Y. Wei, C. Robbins, Y. Iwamoto, B. Sena, A. Chudnovskiy, P. Panizzi, E. Keliher, J. M. Higgins, P. Libby, M. A. Moskowitz, M. J. Pittet, F. K. Swirski, R. Weissleder, M. Nahrendorf, Rapid monocyte kinetics in acute myocardial infarction are sustained by extramedullary monocytopoiesis. J. Exp. Med. 209, 123-137 (2012).
44. C. S. Robbins, A. Chudnovskiy, P. J. Rauch, J. L. Figueiredo, Y. Iwamoto, R. Gorbatov, M. Etzrodt, G. F. Weber, T. Ueno, N. van Rooijen, M. J. Mulligan-Kehoe, P. Libby, M. Nahrendorf, M. J. Pittet, R. Weissleder, F. K. Swirski, Extramedullary hematopoiesis generates Ly- 6Chigh monocytes that infiltrate atherosclerotic lesions. Circulation 125, 364-374 (2012).
45. X. Y. Yeap, S. Dehn, J. Adelman, J. Lipsitz, E. B. Thorp, Quantitation of acute necrosis after experimental myocardial infarction. Methods Mol. Biol. 1004, 115-133 (2013).
46. Y. Xu, N. H. Hunt, S. Bao, The role of granulocyte macrophage-colony- stimulating factor in acute intestinal inflammation. Cell Res. 18, 1220-1229 (2008).
47. R. F. Hamilton Jr., S. A. Thakur, J. K. Mayfair, A. Holian, MARCO mediates silica uptake and toxicity in alveolar macrophages from C57BL/6 mice. J. Biol. Chem. 281, 34218-34226 (2006).
48. M. S. Arredouani, A. Palecanda, H. Koziel, Y. C. Huang, A. Imrich, T. H. Sulahian, Y. Y. Ning, Z. Yang, T. Pikkarainen, M. Sankala, S. O. Vargas, M. Takeya, K. Tryggvason, L. Kobzik, MARCO is the major binding receptor for unopsonized particles and bacteria on human alveolar macrophages. J. Immunol. 175, 6058-6064 (2005).
49. F. J. Geske, R. Lieberman, R. Strange, L. E. Gerschenson, Early stages of p53-induced apoptosis are reversible. Cell Death Differ. 8, 182-191 (2001).
50. M. S. Arredouani, F. Franco, A. Imrich, A. Fedulov, X. Lu, D. Perkins, R. Soininen, K. Tryggvason, S. D. Shapiro, L. Kobzik, Scavenger receptors SR-AI/II and MARCO limit pulmonary dendritic cell migration and allergic airway inflammation. J. Immunol. 178, 5912-5920 (2007).
51. M. Dahl, A. K. Bauer, M. Arredouani, R. Soininen, K. Tryggvason, S. R. Kleeberger, L. Kobzik, Protection against inhaled oxidants through scavenging of oxidized lipids by macrophage receptors MARCO and SR-AI/II. J. Clin. Invest. 117, 757-764 (2007).
52. N. Matsushita, H. Komine, A. Grolleau-Julius, S. Pilon-Thomas, J. J. Mulé, Targeting MARCO can lead to enhanced dendritic cell motility and anti-melanoma activity. Cancer Immunol. Immunother. 59, 875-884 (2010).
53. K. L. Tyler, K. Khalili, Natalizumab and progressive multifocal leukoencephalopathy: Highlights of the International Workshop on JC Virus/PML and Multiple Sclerosis, June 3-4, 2005, Philadelphia PA. Rev. Neurol. Dis. 2, 144-149 (2005).
54. S. Bao, E. D. Carr, Y. H. Xu, N. H. Hunt, Gp91phox contributes to the development of experimental inflammatory bowel disease. Immunol. Cell Biol. 89, 853-860 (2011).
55. H. Wu, G. Chen, K. R. Wyburn, J. Yin, P. Bertolino, J. M. Eris, S. I. Alexander, A. F. Sharland, S. J. Chadban, TLR4 activation mediates kidney ischemia/reperfusion injury. J. Clin. Invest. 117, 2847-2859 (2007).
56. H. Wu, M. L. Craft, P. Wang, K. R. Wyburn, G. Chen, J. Ma, B. Hambly, S. J. Chadban, IL-18 contributes to renal damage after ischemia-reperfusion. J. Am. Soc. Nephrol. 19, 2331-2341 (2008).
57. H. Wu, J. Ma, P. Wang, T. M. Corpuz, U. Panchapakesan, K. R. Wyburn, S. J. Chadban, HMGB1 contributes to kidney ischemia reperfusion injury. J. Am. Soc. Nephrol. 21, 1878-1890 (2010).
58. S. J. Cordwell, A. V. Edwards, K. A. Liddy, L. Moshkanbaryans, N. Solis, B. L. Parker, A. S. Yong, C. Wong, L. Kritharides, B. D. Hambly, M. Y. White, Release of tissue-specific proteins into coronary perfusate as a model for biomarker discovery in myocardial ischemia/reperfusion injury. J. Proteome Res. 11, 2114-2126 (2012).